In addition to dopaminergic neuronal loss in the SN and the onset of motor symptoms in PD, these changes cause microgliosis, mitochondrial failure, oxidative stress, and inflammation
Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death
Dual agonists (e.g., Tirzepatide): Act on both GLP-1 and GIP receptors to more vigorously improve blood sugar control and weight loss
Common applications include: Metabolic and obesity research: Studying how amylin receptor activation influences body weight, food intake, and metabolic control in preclinical and clinical research settings
This GH release encourages fat metabolism, lean muscle growth, and tissue repair while minimizing the risk of side effects commonly associated with GH stimulation, such as elevated cortisol levels